These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors. Latronico T; Mascia C; Pati I; Zuccala P; Mengoni F; Marocco R; Tieghi T; Belvisi V; Lichtner M; Vullo V; Mastroianni CM; Liuzzi GM Int J Mol Sci; 2016 Mar; 17(4):455. PubMed ID: 27023536 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283 [TBL] [Abstract][Full Text] [Related]
4. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069 [TBL] [Abstract][Full Text] [Related]
6. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease. Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289 [TBL] [Abstract][Full Text] [Related]
8. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis. Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908 [TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis. Tsai HC; Shi MH; Lee SS; Wann SR; Tai MH; Chen YS Clin Microbiol Infect; 2011 May; 17(5):780-4. PubMed ID: 21521415 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis. Hsieh CS; Chuang JH; Huang CC; Chou MH; Wu CL; Lee SY; Chen CL J Pediatr Surg; 2005 Oct; 40(10):1568-73. PubMed ID: 16226986 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury. Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327 [TBL] [Abstract][Full Text] [Related]
12. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome. Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620 [TBL] [Abstract][Full Text] [Related]
14. Serum MMPs and TIMPs: may be predictors of breast carcinogenesis? Zagouri F; Sergentanis TN; Kalogera E; Provatopoulou X; Chrysikos D; Zografos E; Bletsa G; Flessas I; Papadimitriou CA; Zografos GC; Gounaris A Clin Chim Acta; 2011 Mar; 412(7-8):537-40. PubMed ID: 21130755 [TBL] [Abstract][Full Text] [Related]
15. [Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis]. Klimiuk PA; Sierakowski S; Chwiećko J Pol Arch Med Wewn; 2003 Feb; 109(2):119-23. PubMed ID: 12879774 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. Dietmann A; Helbok R; Lackner P; Issifou S; Lell B; Matsiegui PB; Reindl M; Schmutzhard E; Kremsner PG J Infect Dis; 2008 Jun; 197(11):1614-20. PubMed ID: 18700258 [TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis. Kathamuthu GR; Kumar NP; Moideen K; Nair D; Banurekha VV; Sridhar R; Baskaran D; Babu S Front Immunol; 2020; 11():419. PubMed ID: 32218787 [TBL] [Abstract][Full Text] [Related]
18. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Lorenzl S; Buerger K; Hampel H; Beal MF Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439 [TBL] [Abstract][Full Text] [Related]
19. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109 [TBL] [Abstract][Full Text] [Related]
20. Alterations in serum MMP and TIMP concentrations following chronic heroin abuse. Kovatsi L; Batzios S; Nikolaou K; Fragou D; Njau S; Tsatsakis A; Karakiulakis G; Papakonstantinou E Toxicol Mech Methods; 2013 Jun; 23(5):377-81. PubMed ID: 23256456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]